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LINE-1 retrotransposons are fast-evolving mobile
genetic entities that play roles in gene regulation,
pathological conditions, and evolution. Here, we
show that the primate LINE-1 50UTR contains a pri-
mate-specific open reading frame (ORF) in the anti-
sense orientation that we named ORF0. The gene
product of this ORF localizes to promyelocytic leuke-
mia-adjacent nuclear bodies. ORF0 is present in
more than 3,000 loci across human and chimpanzee
genomes and has a promoter and a conserved
strong Kozak sequence that supports translation.
By virtue of containing two splice donor sites,
ORF0 can also form fusion proteins with proximal
exons. ORF0 transcripts are readily detected in
induced pluripotent stem (iPS) cells from both pri-
mate species. Capped and polyadenylated ORF0
mRNAs are present in the cytoplasm, and endoge-
nous ORF0 peptides are identified upon proteomic
analysis. Finally, ORF0 enhances LINE-1 mobility.
Taken together, these results suggest a role for
ORF0 in retrotransposon-mediated diversity.
INTRODUCTION
Transposable elements (TEs) are mobile genetic elements that
can alter their chromosomal locations in the host genomes.
TEs, first discovered by Barbara McClintock in maize
(McClintock, 1950), are abundantly present in nearly all genomes
studied to date; they influence gene expression and shape the
genomes over evolutionary time (Huang et al., 2012). There are
two classes of TEs based on their transposition mechanisms:
DNA transposons and retrotransposons. DNA transposons
mobilize with a cut-and-paste mechanism, whereas retrotrans-posons move by copy-and-paste via an RNA intermediate
(Kleckner, 1990; Luan et al., 1993). Autonomous elements from
both classes are defined as TEs that encode the proteins
required for transposition, whereas non-autonomous elements
depend on such proteins to be provided in trans. In primate ge-
nomes, most active TEs belong to the retrotransposon families.
Of these, LINE-1 (L1) elements are the only autonomous ele-
ments that are currently active (Dewannieux et al., 2003; Hancks
et al., 2011) and thus have directly and indirectly contributed to
30% of the human genome (Lander et al., 2001). At present,
themajority of L1 elements are inactive, due to accumulatedmu-
tations as well as 50 truncations that are common during the inte-
gration process, thus reducing the number of estimated active
elements to 80 per genome (Brouha et al., 2003). The first
active L1 element was isolated through analysis of mutagenic
L1 insertions into the factor VIII gene in hemophilia A patients
(Dombroski et al., 1991). Since then, retrotransposon germline
insertions have been linked to 100 human diseases (Hancks
and Kazazian, 2012).
Intact, active L1s are 6 kb long and contain a 50UTR, two
open reading frames (ORF1 and ORF2) and a short 30UTR (Scott
et al., 1987). The L1 50UTR has promoter activity in both the
sense and antisense (ASP) directions (Speek, 2001; Swergold,
1990). ORF1 encodes an 40 kDa RNA-binding protein that is
required for L1 transposition (Kolosha and Martin, 1997; Moran
et al., 1996). However, ORF1 does not have any significant
sequence similarity to known proteins (Goodier et al., 2007).
ORF2 is a large protein at 150 kDa with endonuclease and
reverse transcriptase activities (Mathias et al., 1991). These ac-
tivities, as well as the function of a cysteine-rich region at the C
terminus, are important for L1 mobility (Feng et al., 1996; Moran
et al., 1996).
Regardless of their ability to mobilize, L1s contribute to tran-
scriptome diversity and gene regulation (Cordaux and Batzer,
2009). Transcription initiated in both directions can extend
beyond the L1 sequence but, due to the presence of a polyA
signal at the end of the 30UTR, most sense transcripts end withinCell 163, 583–593, October 22, 2015 ª2015 Elsevier Inc. 583
the element. However, extensions into the genomic flank are
also frequently observed and can lead to 30 transductions (Moran
et al., 1999). Analyses of cloned cDNAs provide evidence of anti-
sense transcripts that are spliced into exons in the neighboring
genomic sequences (Macia et al., 2011; Ma¨tlik et al., 2006;
Wheelan et al., 2005). Recent studies have focused on specific
examples of spliced transcripts with a focus on disease, and a
number of L1-driven transcripts have been shown to exist in
cancer cells (Cruickshanks and Tufarelli, 2009). In addition to
driving genes, antisense transcripts have been linked to chro-
matin modifications that influence gene expression (Cruick-
shanks et al., 2013).
A recent analysis of L1s in primates showed that, while ORF1
and ORF2 sequences have been relatively well conserved,
acquisition of new 50UTRs frequently occurred during primate
evolution, providing the diversity that resulted in selection of
the current 50UTR (Khan et al., 2006). With the above in mind,
we set out to improve our understanding of the properties of
the primate L1 50UTR. Here, we show that the currently active
primate L1 50UTR has well-conserved properties that support
translation of an ORF that we have named ORF0. ORF0 is en-
coded by a primate-specific antisenseORF that lies downstream
from the ASP and has a strong, well-conserved Kozak sequence.
The gene product of this ORF is predominantly nuclear and local-
izes to promyelocytic leukemia (PML)-adjacent bodies. ORF0
also has two prominent splice donor (SD) sites at nucleotides
106 and 191 (amino acids 35 and 64) that can act in concert
with splice acceptors (SAs) in downstream genomic sequences
to generate fusion proteins. ORF0 mRNAs are capped, polyade-
nylated, associated with ribosomes, and upon immunoaffinity
purification, peptides from endogenous ORF0 products can be
detected by mass spectrometry. Lastly, overexpression of
ORF0 leads to a modest but significant increase in L1 mobility.
Thus, we have identified and begun to characterize a third ORF
from primate L1 retrotransposons.
RESULTS
Identification of an ORF in the Human Antisense
L1 50UTR
We started by analyzing the antisense 50UTR for the presence of
ORFs that have an upstream promoter, start with ATG, and have
a strong Kozak sequence determined by the presence of A/G in
position 3 and G at position +4 (Kozak, 1987). Only one poten-
tial ORF exists that meets these criteria and, due to its 50 position
with respect to ORF1 and ORF2, we have called it ORF0. ORF0
lies between nucleotides 452–236 from the 50 end of LINE-1 in
the antisense orientation and contains two SD sites (red boxes)
within the potential coding sequence (Figure 1A). There are
781 loci that could encode full-length (FL) ORF0 in the human
genome; the consensus sequence for the FL ORF0 protein ob-
tained from these loci is shown in Figure 1A. The chimp ORF0
consensus sequence from 395 FL ORF0 loci is identical to
that of the human.
The previously mapped L1 ASP lies upstream of ORF0, with
some overlap (Speek, 2001). This overlap prompted us to check
whether the promoter activity resided upstream of the initiator
methionine (1st Met) of ORF0. Results from luciferase reporter584 Cell 163, 583–593, October 22, 2015 ª2015 Elsevier Inc.assays suggested that promoter activity was upstream but not
downstream of ORF0 1st Met, and we further mapped a minimal
ORF0 promoter of 150 bp that had similar activity to the previ-
ously described L1 ASP (Figure 1B). We also cloned a number of
polymorphic ORF0 promoters upstream of luciferase and GFP
reporters. While variable, all the tested promoters were active
(data not shown). This finding is consistent with previous obser-
vations that a high percentage of L1 50UTRs have antisense
promoter activity (Macia et al., 2011). Next, in vitro translation
of HA-tagged ORF0 was tested in rabbit reticulocyte lysates
and confirmed with western blot analysis (Figure 1C).
To investigate whether this potential ORF could be translated
in human cells, we removed the stop codon of ORF0 and cloned
it upstream of a promoterless, in-frame GFP coding sequence
that lacked the first ATG. Upon transfection, western blot anal-
ysis showed that, indeed, the ORF0 promoter and the context
around the 1st Met of ORF0 were sufficient to translate the
ORF0-GFP fusion protein (Figure 1D).
ORF0 Protein Is Predominantly Nuclear and Present in
PML-Adjacent Foci
To analyze the subcellular localization of ORF0, we generated a
GFP-tagged ORF0 clone in an L1 context (GFP-ORF0-L1). Since
two SD sequences that were often involved in generation of
spliced antisense transcripts (Speek, 2001) fell within ORF0, to
allow detection of both spliced and unspliced products, GFP
was placed at the N terminus but downstream of the Kozak
context of ORF0 to minimize any effects on translation initiation
(Figure 1E). Western blot analysis confirmed that GFP-ORF0
fusion protein was generated (Figure 1E). Importantly, when
the 1st Met of ORF0 was mutated to threonine (M1T), we
observed that GFP signal was lost, showing that translation
started from the 1st Met of ORF0 (Figure 1F) and ruling out any
potential upstream translation initiation. Furthermore, addition
of a poly A signal downstream of ORF0 at the end of the L1 did
not change protein localization, suggesting that the produced
ORF was contained within the L1 and was not a splicing product
with the downstream flank (Figure S1A). We also fused ORF0 to
mCherry (29% identity to EGFP) and observed a very similar
pattern, suggesting that the sequence of the tag was not driving
the localization (Figures S1B and S1C). Interestingly, ORF0, but
not GFP-alone from the same plasmid backbone, was localized
predominantly in nuclear foci in the majority of cells (Figures 1F
and S1D–S1F). As predicted by the charge distribution of amino
acid residues, the C terminus portion of ORF0 was required for
nuclear localization (Figure S1G). Since a number of ORF0 vari-
ants may be encoded due to polymorphisms in L1 sequences,
we cloned some of these variants and observed that, unless
truncated, most localized similarly (data not shown).
Based on the numbers and distribution of foci, we hypothe-
sized that ORF0 localization could be related to PML bodies.
PML bodies are nuclear proteinaceous structures often associ-
ated with the nuclear matrix and are involved in a wide variety
of processes that may influence L1 biology: stress, anti-viral
and DNA damage response, transcriptional regulation, hetero-
chromatin, and post-translational protein modifications (Ber-
nardi and Pandolfi, 2007). Indeed, in cells transfected with
PML-IV-GFP and mCherry-ORF0, high-magnification imaging
Figure 1. Identification of ORF0 in L1 50UTR
(A) Location of ORF0 in L1. The start codon ATG
and the stop codon TGA are labeled red in the
antisense orientation. The positions of splice
donor sites within the coding sequence are indi-
cated with red squares. Consensus protein
sequence of full-length ORF0 based on 781
potential ORF0 loci in the human genome.
(B) Upstream 150 bp region of ORF0 has pro-
moter activity. Luciferase assays were performed
to determine promoter activity of the L1 50UTR
regions shown in the panel below the graph. Red
and orange lines represent antisense and sense
strands, respectively. DSMet refers to down-
stream of initiator methionine. Data are presented
as mean ± SEM. *Denotes p < 0.05 significance
between indicated groups using t test. CTRL
denotes control.
(C) ORF0 can be translated in vitro. HA-tagged
ORF0 production was monitored by western
blotting.
(D) Production of ORF0-GFP fusion protein was
detected by GFP western blot. The C-terminal
GFP tagged ORF0 construct driven by the up-
stream region of ORF0 is shown at the bottom.
Black arrows indicate GFP alone and the fusion
protein. Red arrow highlights the size shift.
(E) GFP-ORF0 fusion protein was detected by
western blot. Design of GFP-ORF0 construct in L1
context. GFP is cloned at the N terminus of ORF0
downstream of the 1st Met and potential Kozak
context. Red arrow highlights the size shift in the
generated protein.
(F) Translation of GFP-ORF0 is dependent on the
ORF0 initiator methionine. Fluorescent detection
of ORF0 localization upon transfection of the
construct depicted in E into HEK293T cells. WT,
wild-type; M1T, initiator methionine to threonine
mutant. Scale bar, 10 mm.
(G) Most of ORF0 protein localizes to PML-adja-
cent nuclear bodies. Confocal imaging of cells
transfected with mCherry-ORF0- and GFP-PML-
IV-encoding plasmids. Scale bar, 4 mm.
(H) Spot representation of ORF0 (red) and PML
(green) foci. Images from 90 and 180 relative to
Movie S1 are shown. Scale bar, 1 mm.
See also Figure S1.showed that ORF0was present in PML-adjacent foci (Figure 1G).
Spot analysis of confocal z series confirmed this observation
(Figure 1H; Movie S1).
A Large Number of ORF0 Loci with a Conserved
Functional Kozak Context Exist in Primate Genomes
We sought to determine howmany loci could potentially encode
ORF0 in the human and chimp genomes. Taking splicing into
consideration, we scanned these genomes for potential ORF0
loci that are untruncated up to the two commonly used SD sites
and have an adjacent GT dinucleotide. Human and chimp ge-
nomes have 3,528 and 3,299 such loci (of which 974 and
745 are species-specific, respectively) that have the potential
to splice into the genomic flanks and generate fusion proteins
(Figures 2A and 2B). All FL ORF0 loci contain at least one SD
and, as a result, they are present in this set. L1 family classifica-tion of ORF0 loci are shown in Table S1. Considering insertional
polymorphisms within populations and somatic insertions, the
number of ORF0 loci may be even larger. Analysis of human
and chimp genomes for ORF0 loci revealed a conserved strong
Kozak context around the first ATG (Figure 2C). To test the func-
tionality of the consensus wild-type ORF0 Kozak (WT ORF0),
we mutated it to an optimal Kozak sequence (OPT) as well as a
3/+4 mutant (MT ORF0). Expression of GFP-ORF0 was com-
parable between WT ORF0 and OPT, whereas the 3/+4 muta-
tion abolished translational activity (Figures 2D and S2A).
We also extended our ORF0 analysis across mammalian ge-
nomes and found ORF0 loci with homology throughout the po-
tential coding sequence, only in the genomes of Catarrhini.
Within this parvorder of primates, OldWorldmonkey and ape ge-
nomes contain on average 50 and 2,500 such ORF0 loci,
respectively. Consensus Kozak sequences derived from theseCell 163, 583–593, October 22, 2015 ª2015 Elsevier Inc. 585
Figure 2. More than 3,000 Potential ORF0
Loci with a Conserved and Functional Ko-
zak Sequence Exist in the Human and
Chimp Genomes
(A and B) Chromosomal locations of ORF0 loci
in the human and chimp reference genomes. The
human and chimp genomes have 3,528 and
3,299 loci, respectively, that have the potential to
splice into the genomic flanks and generate fusion
proteins.
(C) ORF0 loci have a conserved strong Kozak
context. Logo of Kozak sequences of ORF0 loci in
human and chimp genomes. Start codon is un-
derlined with red, and important nucleotides for
translation initiation are underlined with black.
(D) The ORF0 Kozak sequence is functional.
Western blot analysis of ORF0-GFP fusions driven
by optimal (OPT), wild-type (WT ORF0), and
mutant (MT ORF0) Kozak sequences from the
GFP-ORF0-L1 construct. Arrow highlights the
GFP-ORF0 protein.
(E) Basic phylogenetic analysis of ORF0 se-
quences in human L1PA families. ORF0 coding
sequences were extracted from L1PA family
consensus sequences and used in generating the
maximum likelihood tree.
(F) Alignment of consensus ORF0 sequences
derived from Catarrhini species. Charged residues
are labeled in red and blue for positively
and negatively charged, respectively. These
consensus sequences were used in building
the maximum likelihood tree for these primate
species.
See also Figure S2 and Table S1.loci suggest that the ORF0 Kozak context is conserved,
including the G3 and G+4 positions (red boxes) (Figure S2B).
In New World monkeys, a very small number of ORF0 loci with
limited N terminus homology were observed; however, due to
the low number, a reliable consensus could not be built and
thus these genomes were excluded from further investigation.
We next focused on the ORF0 coding sequences to get a bet-
ter picture of evolutionary conservation of ORF0within human L1
families and across primates. The alignments of ORF0 proteins
from consensus L1PA1–8 sequences (Khan et al., 2006) are
shown in Figure S2C. L1PA1 (that includes L1HS) and L1PA2
have intact SD1 and SD2. L1PA3-L1PA6 families contain a
longer ORF0 due to a frameshift after SD2. In L1PA5 and
L1PA6, SD1 is mutated but SD2 is conserved (data not shown).
L1PA7 and L1PA8 have C termini that are distinct from the other
L1PA families and lack SD1 and SD2. The abovementioned vari-
ation across L1PA families was recapitulated in the maximum586 Cell 163, 583–593, October 22, 2015 ª2015 Elsevier Inc.likelihood tree (Figure 2E). Next, we
generated consensus ORF0 sequences
from the Catarrhines for comparison (Fig-
ure 2F). These primates have very similar
consensus ORF0 proteins, except for the
region between residues 42 and 50.
While all species’ consensus ORF0
sequence contains SD2, rhesus and ba-boons lack SD1 due to a point mutation (Figure S2D). The
maximum likelihood tree from theORF0 sequences of Catarrhine
genomes is shown in Figure 2F.
Capped and Polyadenylated ORF0 mRNAs Are Present
in the Cytoplasm
One would expect ORF0 to be tightly regulated as a transpos-
able element protein. In addition, short ORFs are technically
challenging to uncover (Andrews and Rothnagel, 2014). To
determine whether transcription from ORF0 loci could be de-
tected, we turned to transcriptomic data. Cap analysis of gene
expression (CAGE) data allow the mapping of transcription start
sites (TSSs) and thus make it possible to identify the 50 end of
transcripts that originate from L1 (Faulkner et al., 2009; Shiraki
et al., 2003). Our analysis of CAGE data showed that the majority
of TSSs for antisense RNAs are upstream of ORF0 1st Met, sug-
gesting that most antisense transcripts could have the capacity
Figure 3. ORF0-Gene Fusion Transcripts
Are Expressed in Human and Chimp iPS
Cells
(A) Most of the antisense L1 transcription starts
upstream of ORF0. Cytoplasmic polyA plus K562
CAGE (ENCODE/RIKEN) reads were mapped to
L1HS consensus sequence.
(B) Protein logo of ORF0 loci that are untruncated
until splice donor sites in the human and chimp
genomes. Sequences from SD1 and SD2 loci are
represented as protein sequence logos. Positions
of SD1 and SD2 are indicated with black boxes.
(C and D) Table of top 25 protein-coding genes, for
which RNA-Seq reads were detected at the splice
junction with ORF0 in human and chimp iPS cells.
Red-labeled genes have ORF0 fusions due to
species-specific L1 insertions. Blue labeling rep-
resents genes for which ORF0 fusion transcripts
were detected in both human and chimp iPS
samples. Transcripts of black-labeled gene fu-
sions are detected only in one species. The ratios
of ORF0 isoforms with respect to the total (i.e.,
ORF0 + annotated gene isoforms) are shown in the
ratio column. Table was sorted for ratio from high
to low.
(E) Ribosome footprinting data from HEK293T
cells were mapped to the L1HS consensus
sequence.
See also Figure S3 and Table S2.to encode ORF0 (Figure S3A). More importantly, ORF0 mRNA
could be detected not only in whole cell but also in the cyto-
plasmic fraction; capped and polyadenylated ORF0 mRNAs
were present in the cytoplasm (Figure 3A).
Most intronic L1s are in the reverse orientation with respect to
their host genes (Smit, 1999), including L1s with intact ORF0:
650 protein coding genes in human and450 in chimp contain
ORF0 loci in the same direction as host gene transcription (data
not shown), raising the possibility of a number of ORF0-host
gene fusion events. The sequence logos of ORF0 loci in human
and chimp that have the potential to splice, along with commonly
used SD sites, are shown in Figure 3B.
To identify ORF0 fusion transcripts in human and chimp,
we turned to RNA sequencing (RNA-seq) data that we had
generated from iPS cells (Marchetto et al., 2013). Indeed,Cell 163, 583–593,RNAs for a number of fusion events
were observed in both species (Figures
3C, 3D, and S3B). Analysis of the contri-
bution of ORF0 isoforms (iso-0) to the
expression of these genes suggested
that some genes were primarily driven
by ORF0 in iPS cells, whereas for other
genes, iso-0 contribution ranged from
moderate to minor (Figures 3C and 3D;
Table S2). We also extended our analysis
to fibroblast-iPS pairs and observed that
ORF0 transcript levels were dramatically
upregulated in both human and chimp
pluripotent stem cells compared torespective source fibroblasts (Figures S3C and S3D and data
not shown).
ORF0 mRNAs Are Associated with Ribosomes
The presence of capped ORF0 mRNAs with a polyA tail in the
cytoplasm as well as fusion transcripts with proximal exons of
protein coding genes prompted us to investigate, by analyzing
ribosome footprinting data, whether ORF0 RNAs were associ-
ated with ribosomes (ribosome footprinting [Ribo-seq]) (Ingolia
et al., 2011). First, we mapped Ribo-seq reads obtained from
HEK293T cell line (Shalgi et al., 2013) to L1HS consensus
sequence (Figure 3E). In the sense orientation, a plateau of ribo-
some footprints was detected for ORF1 but ORF2 signal was
much weaker, a finding that is in accordance with the known
translation levels of ORF1 and ORF2 proteins (Alisch et al.,October 22, 2015 ª2015 Elsevier Inc. 587
Figure 4. ORF0 Protein: Intronic Expres-
sion, Endogenous Detection, and Effect on
L1 Mobility
(A) GFP-ORF0 can be expressed from an intronic
position in an ORF0 initiator Met-dependent
manner. The GFP-ORF0-L1 cassette (wild-type or
M1T) was cloned in the antisense orientation in an
intron. GFP was detected by confocal micro-
scopy. Scale bar, 10 mm.
(B)Western blot analysis of GFP-ORF0 expression
suggests that intronic ORF0 protein is produced
but is not full-length. The fusion protein expressed
from the intronic construct is indicated with the
black arrow.
(C) Functionality of ORF0 antibody was tested
using overexpressed protein, by immunoprecipi-
tation, and subsequent western blotting.
(D) Schematic description and sequences of
identified ORF0 peptides. The first peptide (black
square) resides upstream of SD2. The second
peptide (red square) spans the splice junction of
proteins formed through splicing between SD2
and SA1. The third peptide (green square) is
located downstream of SA1 within the L1
sequence.
(E–G) Spectra of peptides (#1, #2, and #3) identi-
fied by proteomic searches. Green peaks in (G)
represent neutral losses.
(H and I) Overexpression of ORF0 protein, but not
ORF0 RNA, increases L1 mobility based on lucif-
erase L1 reporter in HEK293T cells and human
NPCs. Potential antisense RNA effects were
controlled for by using a single-nucleotide mutant
ORF0 that replaces the initiator Methionine with
Threonine. Data are presented as mean ± SEM.
*Denotes p < 0.05 significance between indicated
groups using t test.
See also Figure S4.2006). In the antisense orientation, a strong signal was evident
for ORF0 (Figure 3E). Interestingly, this signal also extended
beyond the FL ORF0 sequence, which may be due to within-
L1 splicing events (see below and data not shown) or L1s from
older families, in which the encoded consensus ORF0 extends
until the end of L1 (see Figure S2C). Even though reads obtained
by ribosome footprinting were shorter than those gained from
RNA-seq, we observed spliced ORF0 footprints of in-frame fu-
sions to SCAMP1, SLC44A5, GJB4, HTR2C, and RABGAP1L
(driven by a human-specific L1 insertion). Thus, the influence
of ORF0 may not necessarily be limited to L1 biology.
ORF0-Downstream Exon Fusion Protein Is Expressed
To test whether ORF0 could be transcribed and translated from
an intronic position, we cloned the GFP-ORF0-L1 cassette in the588 Cell 163, 583–593, October 22, 2015 ª2015 Elsevier Inc.antisense orientation within a natural
human intron. Upon transfection of this
construct into cells, GFP-ORF0 was ex-
pressed. Moreover, translation started
at the ORF0 1st Met, as the M1T muta-
tion abolished expression (Figure 4A).
Interestingly, GFP signal was localizedthroughout the cell instead of in nuclear foci. This difference in
localization was explained by western blot analysis, which
showed that intronic GFP-ORF0 fusion protein was different
from GFP alone or GFP-FL ORF0, suggesting that a spliced
product was translated (Figure 4B). Generation of a fusion pro-
tein via splicing between SD1 of ORF0 and the downstream
exon was confirmed by sequencing (data not shown).
Proteomic Detection of Endogenous ORF0 Peptides
Having observedORF0 transcripts aswell as expression from re-
porter plasmids, we investigated endogenous ORF0 products.
Proteomic identification of ORF0 requires detection of peptides
within unspliced ORF0 or N terminus ORF0 fragments of fusion
proteins. Therefore, due to the small size of ORF0, a limited num-
ber of possible peptides are available for detection by mass
spectrometry. In addition, the distribution of the target residues
(K and R) for trypsin, the most commonly used enzyme for pro-
teomics, leads to the generation of non-ideal peptide fragment
sizes (see Figure 2F): the N terminus is poor in these residues
whereas the C terminus is rich, generating a very small number
of peptides optimal for mass spectrometry. In fact, only one pep-
tide from the main body of ORF0 could be detected in our mass
spectrometry analysis of overexpressed ORF0 (Figure S4A).
Nevertheless, we proceeded to attempt detection of endoge-
nous ORF0 peptides. We started by raising polyclonal anti-ORF0
antibodies targeting the consensus L1HS FL-ORF0 protein.
Upon confirmation that the ORF0 antibody worked for immu-
noaffinity enrichment from overexpressed HA-ORF0 extracts
(Figure 4C), we turned to the cultured cell type that expressed
the highest levels of ORF0 transcripts as a class: human plurip-
otent stem cells. In parallel, we computationally generated
an RNA expression-based ORF0 proteomics database that
included potential unspliced and spliced ORF0 proteins. The
combined ORF0-Human Uniprot database was used in spectra
searches. Next, immunoprecipitates from control and ORF0
antibody were subjected to mass spectrometry analysis. Liquid
chromatography-tandem mass spectrometry (LC-MS/MS)
spectra searches did not find any ORF0 fragments in control
antibody samples. However, searches of anti-ORF0 immunopre-
cipitates led to identification of endogenous ORF0 peptides (Fig-
ures 4D–4G). Spectra obtained from overexpressed peptides
for comparison and further information on all the spectra are pre-
sented in Figures S4A–S4D. The first peptide (black square) re-
sides upstream of SD2. The second peptide (red square) spans
the splice junction of proteins formed through splicing between
SD2 and SA1 (SA1: based on RNA-seq analysis, a functional
splice acceptor site 336 nucleotides downstream of the ORF0
start site in the L1 50UTR antisense). The third peptide (green
square) is located downstream of SA1 within the LINE-1
sequence (Figure 4D). There are multiple loci that can encode
the observed ORF0 peptides and the exact identities of source
loci are currently unknown.
ORF0 Enhances L1 Mobility
Given the fact that the ORF0 coding sequence resides in the L1
50UTR with bidirectional promoter activity, the most parsimo-
nious function for ORF0 would be a potential effect on L1
mobility. Human L1s driven by CMV or CAG promoters are mo-
bile (Moran et al., 1996); thus it is clear that ORF0 is not essential
for L1 activity. We attempted to test potential in cis effects of
ORF0 mutations; however, this task was hampered by the fact
that the ORF0 sequence overlaps with the forward L1 promoter
(data not shown). Thus, we overexpressed ORF0 in trans and
tested for its effect on L1 mobility. To prevent any direct anti-
sense L1 RNA effect due to transcription of ORF0, we used a
CAG promoter-driven L1 reporter. In HEK293T cells, ORF0
expression led to a 41% increase in L1 mobility (Figure 4H).
To rule out any indirect effects of expressing antisense L1
RNA, we also used the single nucleotide mutant control, ORF0
M1T, that did not produce ORF0 protein. This construct had no
effect on L1 mobility, strongly suggesting that ORF0 protein
was responsible for the observed increase (Figure 4H). Impor-
tantly, wild-type, but not M1T mutant, ORF0 also increased L1mobility in human embryonic stem (ES) cell-derived neural pro-
genitors (human NPC) by 38% (Figure 4I), bringing forth the
possibility that ORF0 may contribute to somatic variation by
enhancing L1 activity in pluripotent cells.
DISCUSSION
The constant competition between transposable elements and
host-protective mechanisms contributes to genome evolution
(Daugherty and Malik, 2012; Slotkin and Martienssen, 2007). It
is currently unclear whether L1 antisense promoter activity has
been a major factor in this arms race. From an L1 perspective,
antisense transcription can positively influence sense expres-
sion through recruitment of transcriptional machinery, inducing
open chromatin structure or via formation of a non-coding
RNA. On the other hand, expression of antisense RNA can
lead to dsRNA formation, which may trigger an RNAi response
(Ma¨tlik et al., 2006; Yang and Kazazian, 2006). Our results sug-
gest that, in addition to the aforementioned roles, L1 50UTR
has the ability to initiate translation in the antisense direction.
ORF0 is present in more than2,500 loci in the ape genomes,
whereas this number is much smaller in the Old World monkeys.
While some of this difference may be related to variable genome
sequence quality, we expect this difference to mostly represent
L1 biology. The alignment of ORF0 sequences from human
L1PA1–8 suggests that the main difference between these fam-
ilies is the C terminus of ORF0. We have also noticed that the se-
quences around the ORF0 translation start site influence forward
promoter activity. It is possible that the translation activity in the
antisense L1 50UTR is coupled with the forward promoter activ-
ity, and thus the N terminus is more conserved with respect to
the rest of the ORF0 sequence due to evolutionary pressure. If
that indeed is the case, translation activity in rhesus and baboon
may generate distant relatives of the ape ORF0. Consistent with
this hypothesis, searches for ORF0 in New World monkey ge-
nomes reveal a very small number of loci that have homology
to human ORF0, with similarity only at the N terminus. Consid-
ering the fact that L1 retrotransposons recruit new 50UTRs over
time, it is conceivable that distant primates such as marmosets
and squirrel monkeys may have significantly different 50UTRs.
Improved primate genome sequence quality and future experi-
mentation will allow the testing of these possibilities.
Expression of ORF0, but not an untranslated point mutant
version, enhances L1 activity from L1 luciferase mobility reporter
in human cells, suggesting a role for ORF0 protein in L1 activity.
We currently do not know the mechanism of this effect. Similar
to ORF1, ORF0 does not share any extensive homology with
known genes, so it is not possible to propose a domain-based
prediction. However, ORF0 is a highly positively charged protein
that may act by binding to nucleic acids. The PML proximity to
ORF0 is intriguing, especially given that a large number of pro-
teins are recruited to PMLbodies depending on the cellular state,
with stress playing a prominent role in determining the content as
well as the morphology of PML bodies. Interestingly, PML is
involved in antiviral responses and protects cells from viral infec-
tions. Some viral proteins target the integrity of PML bodies and a
large number of components are transcriptionally regulated by
the interferon pathway (Everett and Chelbi-Alix, 2007). WhetherCell 163, 583–593, October 22, 2015 ª2015 Elsevier Inc. 589
localization adjacent to PMLs is reflective of ORF0 function or the
cell’s response remains to be seen. It is possible that ORF0, anal-
ogous to some viral proteins, may interfere with the functions of
PML and enhance mobility. Further studies will be required to
gain insight into the mechanism of action of ORF0.
The influence of ORF0 may not necessarily be limited to L1
biology. Our transcriptomic analysis suggests that exons of
host genes provide splice acceptor sites for intronic or proximal
ORF0 loci. Overall, ORF0 expression levels correlate with the
pluripotency of the cell types and ORF0-proximal exon fusion
products are detected by proteomics. While any effects of
ORF0 expression on the host or proximal gene would be context
and sequence dependent, one could make certain predictions. If
the downstream exon is in frame with respect to ORF0 upon
splicing, the N terminus of the host protein would be replaced
by an ORF0 variant, which could alter the localization and/or
function. Out-of-frame ORF0 fusions would contain amino acids
from an alternative frame of the gene and most would encounter
a stop codon. Such transcripts, depending on the context, might
be expressed or be subject to nonsense-mediated decay (NMD).
By virtue of high copy numbers and sequence variants, one
would expect to see varying degrees of NMD response. In addi-
tion, cell-state transitions, stress, and crosstalk with the RNAi
pathway might provide opportunities for NMD targets to be
translated (Kervestin and Jacobson, 2012). In cases of fusions
of ORF0 located upstream of coding sequences, ORF0 might
act as an upstreamORF (uORF). Since uORF function is affected
by the length and sequence of the uORF as well as by the dis-
tance between the upstream and the main ORF, variations in
ORF0 sequences could result in differential translation regulation
(Andrews and Rothnagel, 2014).
L1s, as the sole autonomously active retrotransposons in pri-
mate genomes, continue to shape our genomes. Our data sug-
gest that, in addition to their previously ascribed roles in gene
regulation (Huang et al., 2012), L1s contain a third ORF and
have the ability to generate insertion site-dependent ORFs via
splicing. Considering the fact that transcription and translation
start within L1 elements, these ORF0 variants could be co-regu-
lated. Analogous to the other L1 proteins, disorders such as neo-
plasms (Rodic et al., 2014) may provide opportunities for higher
ORF0 expression, which in turn could contribute to the patholog-
ical phenotypes. It is tempting to speculate that, over evolu-
tionary time, the propensity of ORF0 to splice into proximal
exons may have led to not only gene regulatory changes but
also the emergence of new proteins. The extent to which ORF0
variants contribute to diversity, both in evolutionary terms and
disease conditions, remains to be investigated.EXPERIMENTAL PROCEDURES
Cloning and Mutagenesis
Primers from IDT and Phusion High Fidelity Polymerase (NEB) were used for
PCRs. pGL4.10 (Promega) was the plasmid backbone used for promoter lucif-
erase assays. To test the effect of ORF0 expression on L1 mobility, ORF0 pro-
moter, coding sequence, and the downstream sequence (until the end of L1 in
the antisense orientation) was cloned into pEF-BOS-EX (Mizushima and Na-
gata, 1990). To include any potential within-L1 splicing products and prevent
contribution from the plasmid backbone, a fragment containing stop codons
in all three frames as well as a polyA signal was included immediately down-590 Cell 163, 583–593, October 22, 2015 ª2015 Elsevier Inc.stream of the insert. ORF0-GFP construct was cloned into a modified (SV40
promoter and luciferase removed) pSICheck2 vector (Promega). A modified
(luciferase cassette removed) pYX014 plasmid (Xie et al., 2011) was used for
GFP-ORF0 and mCherry-ORF0 cloning: nucleotide 13 of ORF0 was mutated
(C / G) to generate an AscI site that was used for subsequent cloning of
GFP and mCherry. HA-tagged ORF0 was cloned into pCDNA3.1 for in vitro
translation. GFP-ORF0-L1 cassette was cloned into pEF-BOS-EX with BglII
for intronic expression. Mutagenesis was carried out using the Quick Change
II XL Site Directed Mutagenesis Kit (Agilent Technologies).
RNA Extraction, Reverse Transcription, and cDNA Preparation
RNA was prepared using Trizol (Invitrogen). cDNA was synthesized using the
Superscript III First Strand Synthesis System for RT-PCR (Invitrogen).
Cell Culture and Transfection
HEK293T cells (ATCC) were cultured in DMEM+ GlutaMax medium (Life Tech-
nologies) supplemented with 10% fetal bovine serum (Omega Scientific) and
grown at 37C in 5%CO2. Cells were transfected using polyethylenimine (Pol-
ysciences). HUES6 human ES cells were cultured feeder-free on Matrigel-
coated dishes (BD) using mTeSRTM1 (StemCell Technologies) and passaged
once every 3–4 days using Collagenase type IV enzyme.
Human NPC Derivation, Growth, and Nucleofection
NPCs were differentiated from HUES6 cells through embryoid body and
rosette generation and grown as previously described (Marchetto et al.,
2010). Plasmid delivery into human NPCs was performed by nucleofection
(Lonza/Amaxa Nucleofector, kit VPG-1005).
In Vitro Translation
ORF0 was synthesized in vitro by employing the TNT Coupled Reticulocyte
Lysate System (Promega) using T7 polymerase.
Cell Extracts and Western Blot Analysis
Cells were harvested 2 days post transfection, washed with cold DPBS, and ly-
sates were prepared with ice cold RIPA lysis buffer (50 mM Tris-HCl [pH 7.4],
150 mM NaCl, 0.25% deoxycholic acid, 1% NP-40, 0.1% SDS, and 1 mM
EDTA) containing complete protease inhibitor cocktail with EDTA (Roche) and
1 mM DTT. Lysates were incubated on ice for 15 min, spun at 14,000 3 g for
15 min at 4C, and the supernatants were collected. Primary antibodies: rabbit
a-GFP (1:2000, Santa Cruz sc-8334), rat a-HA peroxidase high-affinity 3F10
(1:1000,Roche), anda-ORF0 (1:300). Secondaryantibody: (1:5,000,GENA934).
Fluorescence Detection
Cells were grown in poly-L-lysine (Sigma) coated 2-well LabTek chamber
slides (Nunc, Fisher), fixed in 4% paraformaldehyde (Sigma) for 15 min at
room temperature, and washed with TBS. The nuclei were stained with DAPI
(1:1,000, Sigma) and the slides were mounted using polyvinyl alcohol with
DABCO (Sigma).
Computational Analyses
Detection and visualization of ORF0 loci in human and chimp genomes: the
UCSC genome browser and Ensembl databases were used to retrieve poten-
tial ORF0 coding sequences, which were subsequently in silico translated. The
Ensembl databases (hg19, panTro4) were used for blastn, allowing some local
mismatch but no gap to obtain ORF0 loci. An alternative method of retrieving
all potential full-length ORF0 sequences from RepeatMasker was tested and
led to very similar results. Custom python scripts and EMBOSS suite (Rice
et al., 2000) were used for identification and characterization of ORF0 loci,
full-length as well as untruncated-until-splice-donor, in the genome. Se-
quences that did not contain a GT dinucleotide at the splice donor site were
removed. Ensembl Karyotype View tool was used for visualization of the
ORF0 loci. Upon confirmation of an annotation error in the Chimp Chr 2B,
the erroneous fragment was removed from the image. The removed region
contained no genes or TEs. Analysis of RNA-seq datasets: RNA-seq (human
and chimp iPS cells) data from GEO: GSE47626 (Marchetto et al., 2013),
GEO: GSE44646 (Wang et al., 2014), GEO: GSE60996 (Gallego Romero
et al., 2015), and ArrayExpress: E-MTAB-2031 (Chan et al., 2013); CAGE
(capped 50 RNA-seq) data from GEO: GSE34448 (Djebali et al., 2012); Ribo-
seq (ribosome footprinting) data from GEO: GSE32060 (Shalgi et al., 2013)
were analyzed from raw FASTQ files in a consistent manner. Reads were
aligned to the reference human (hg19) and chimpanzee (panTro4) genomes
with STAR, which is capable of identifying novel splice junctions (Dobin
et al., 2013). Spliced ORF0 reads were identified by filtering out all multimap-
pers and only considering reads originating from anORF0 locus (direct overlap
of 50 end for stranded RNA-seq and direct overlap of either read end for un-
stranded RNA-seq). Read distributions along L1 were found by aligning reads
to the consensus L1HS element using STAR (Dobin et al., 2013). Read den-
sities along the + and – strands were further normalized based on the total
number of reads in each experiment that were alignable to the full genome. Ra-
tios of isoforms (ORF0 versus total) were determined by comparing the splice
junction reads (j) of ORF0, j(0c), to j(ab), j(bc), j(cd), j(de), where the order of
exons are a-b-0-c-d-e: ratio = average((j(0c)/(average(j(ab),j(bc)) + j(0c))),
(j(0c)/average(j(cd) + j(de)))). This allowed us to get a more reliable estimate
compared to calculations that rely solely on ratio at one exon j(0c) and j(bc)
and to reduce the 30 bias that is observed in polyA-based sequencing. In the
few cases where the ratio is higher than 1 (maximum being 1.2), these ratios
are presented as 1 in the tables (Figures 3C, 3D, and Table S2). Genes in the
tables went through further manual inspection. Proteomic database genera-
tion: RNA-seq reads from human iPS/ES cells were assembled using Cufflinks,
ORF0 containing transcripts were selected and redundancies were removed.
In parallel, ORF0-containing mRNAs that are either ESTs or annotated tran-
scripts were added to the RNA-seq list. The combined list was in silico trans-
lated and appended to the current human Uniprot database for spectra
searches. Determination of species that have ORF0 loci: L1HS/L1Pt
consensus ORF0 sequence (identical) was used in Blat and blast searches
to determine the genomes that contain ORF0 loci. The absence of ORF0 loci
in non-Catarrhine primates was further confirmed by in silico translation of
L1 sequences (with repeat start <1,000) and subsequent search for loci that
can encode a polypeptide with > = 50% identity to ORF0 protein (FL or
SD1-ORF0). Generation of consensus primate ORF0 sequences for phyloge-
netic analysis: ORF0 loci that can encode an untruncated protein >210 nucle-
otides were retrieved via blast searches and subsequent in silico translation
and filtering. The sequences were trimmed to 213 nucleotides (length of FL
ORF0) and used in molecular phylogenetic analysis. Basic molecular phyloge-
netic analysis: Clustal Omegawas used to generate the alignments. The evolu-
tionary history was inferred by using the maximum likelihood (ML) method
based on the JTT matrix-based model. The tree with the highest log likelihood
is shown. A total of 1,000 bootstrap replicates were used for test of phylogeny.
The percentage of trees in which the associated taxa clustered together is
shown next to the branches. Initial tree(s) for the heuristic search were ob-
tained automatically by applying Neighbor-Join and BioNJ algorithms to a ma-
trix of pairwise distances estimated using a JTT model and then selecting the
topology with superior log likelihood value. The tree is drawn to scale, and
branch lengths represent number of substitutions per site. The analysis
involved amino acid sequences and all positions with <95% site coverage
were eliminated. Muscle generated alignments aswell asmaximumparsimony
analysis generated a very similar tree. Evolutionary analyses were conducted
in MEGA6 (Tamura et al., 2013). Analyses using RAxML and PhyML as well as
neighbor joining methods resulted in very similar trees. DNA and protein logos
were generated using WebLogo (Crooks et al., 2004).
L1 Mobility Assays
Luciferase-based L1 mobility reporters used were previously described (Xie
et al., 2011). Cells were transfected/nucleofected with experimental con-
structs together with L1 mobility reporter plasmid pYX017. Luciferase activity
was quantified at day 3 using the Dual Luciferase Reporter 1000 Assay System
(Promega, E1980) and a Perkin Elmer Victor X Luminometer. A two-tailed t test
was used for statistical analysis.
Promoter Activity Assays
Promoter activity was measured by co-transfecting ORF0 promoter con-
structs cloned into pGL4.10 (Promega) along with the normalization vector
phRLTK (Promega). Activity was measured after 2 days, as in the L1 activity
assays. A two-tailed t test was used for statistical analysis.Antibody Generation and Immunoprecipitations
Peptides corresponding to ORF0 amino acid residues 20-34, 33-49 and 50-65
in the L1HS consensus were synthesized, conjugated to KLH and used in gen-
eration of rabbit polyclonal antibodies (Covance). For immunoprecipitations
(IPs), cells were washed with DPBS, collected, and frozen. Cell pellets were
thawed in mDm lysis buffer (25 mM Tris [pH 7.5], 150 mM NaCl, 1.5 mM
MgCl2, 1% Triton X-100, 1 mMDTT, protease inhibitors [Roche]) and superna-
tant from a 15,000 3 g 15 min spin was used in IPs. Control and ORF0 anti-
bodies were conjugated to magnetic beads (Pierce). IP duration was 4–6 hr,
washes were done with the mDm buffer, and beads were heated to 95C for
10–12 min for elution.
Proteomic Sample Prep and Analysis
Samples were precipitated by methanol/chloroform. Dried pellets were dis-
solved in 8 M urea/100 mM Tris, [pH 8.5]. Proteins were reduced with 5 mM
tris(2-carboxyethyl) phosphine hydrochloride (TCEP, Sigma-Aldrich) and alky-
lated with 10 mM iodoacetamide (Sigma-Aldrich). Proteins were digested
overnight at 37C in 2 M urea/100 mM Tris, [pH 8.5], with trypsin (Promega).
Digestion was quenched with formic acid, 5% final concentration and a final
volume of 50 ml.
The digested samples were analyzed on a Fusion Orbitrap tribrid mass
spectrometer (Thermo). Samples were analyzed with injections of 8 ml of the
protein digest per LC/MS run. The digest was injected directly onto a
40-cm, 75-mm ID column packed with BEH 1.7 mm C18 resin (Waters). Sam-
ples were separated at a flow rate of 200 nl/min on a nLC 1000 (Thermo). Buffer
A and B were 0.1% formic acid in water and acetonitrile, respectively. Two
reverse phase gradients of 140 min and 450 min were used to maximize sam-
pling efficiency of the digest. Ninety percent buffer B was used for 10 min final
washes at the ends of gradients. Column was re-equilibrated with 20 ml of
buffer A prior to the injection of sample. Peptides were eluted directly from
the tip of the column and nanosprayed into the mass spectrometer by applica-
tion of 2.5 kV voltage at the back of the column. The Orbitrap Fusion was oper-
ated in a data-dependent mode. Full MS1 scans were collected in the Orbitrap
at 120 K resolution with a mass range of 400–1,600 m/z and an AGC target of
5e5. The cycle time was set to 3 s, and within this 3 s the most abundant ions
per scanwere selected for CIDMS/MS in the ion trap with an AGC target of 1e4
and minimum intensity of 5,000. Maximum fill times were set to 50 ms for MS
scans and 100 and 35 ms for MS/MS scans in the 140 min and 450 min
methods, respectively. Quadrupole isolation at 1.6 m/z was used, monoiso-
topic precursor selection was enabled and dynamic exclusion was used
with an exclusion duration of 5 s.
Protein and peptide identification were done with Integrated Proteomics
Pipeline- IP2 (Integrated Proteomics Applications). Tandem mass spectra
were extracted from raw files using RawConverter and searched with
ProLuCID against ORF0-human UniProt database. The search space included
all fully tryptic and half-tryptic peptide candidates. Carbamidomethylation on
cysteine was considered as a static modification. Data were searched with
50 ppm precursor ion tolerance and 500 ppm fragment ion tolerance. Data
were filtered to 10 ppmprecursor ion tolerance post search. Identified proteins
were filtered using DTASelect (Tabb et al., 2002) and utilizing a target-decoy
database search strategy to control the false discovery rate to 1% at the
protein level.
Imaging
All imaging was carried out using a Zeiss LSM 780 Confocal Microscope. Im-
ages were taken using either a 203 or a 1003 oil objective. The z stack inter-
vals were 1 mm. Image analysis was performed with ZEN (Zeiss) and Imaris
(Bitplane). Both PML and ORF0 foci were identified using the Spots object
on Imaris (Bitplane) using a fixed spot size of 0.5 mm (the measured average
XY diameter of nuclear bodies).
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